mk-6482
Showing 1 - 1 of 1
Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)
Recruiting
- Clear Cell Renal Cell Carcinoma
- Abemaciclib
- MK-6482
-
Boston, Massachusetts
- +1 more
Dec 14, 2022